ConductScience.org, home

Paper41807883

BRAF inhibitor resistance in melanoma: from resistance mechanisms to therapeutic innovations.

Shang Y and 7 others. Mol Biomed, 2026. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. BRAF inhibitor resistance in melanoma: from resistance mechanisms to therapeutic innovations. Papers, record 41807883. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41807883

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
BRAF inhibitor resistance in melanoma: from resistance mechanisms to therapeutic innovations.
PubMed
Journal
Mol Biomed
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2026-08-13
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shang YYan
2Cao TTingping
3Li JJunyan
4Li JJuan
5Zhang LLingnan
6Ma QQiqi
7Feng LLanyan
8Zhao HHailong

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug Resistance, NeoplasmMajor topic
MelanomaMajor topic
Proto-Oncogene Proteins B-rafMajor topic
Protein Kinase InhibitorsMajor topic
Humans
Animals
Tumor Microenvironment
Mutation
Antineoplastic Agents
Epigenesis, Genetic
Molecular Targeted Therapy

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
82060503the National Natural Science Foundation of China Regional ProjectPubMed
QKHJC -ZK [2022] General 622the Guizhou Province Science and Technology Plan ProjectPubMed
QKHJC [2019] 1334the Guizhou Province Science and Technology Plan ProjectPubMed
S202310661178National College Students Innovation and Entrepreneurship Training ProgramPubMed
S202310661167National College Students Innovation and Entrepreneurship Training ProgramPubMed
S2024106612300National College Students Innovation and Entrepreneurship Training ProgramPubMed

Source PubMed

Download CSV of grants

References399

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138941889High levels of soluble CD73 unveil resistance to BRAF inhibitors in melanoma cells.Biomed Pharmacother2024https://conductscience.org/library/papers/38941889PubMed
240063190Let-7a microRNA modulates caspase-3-dependent apoptosis in melanoma cells treated with dabrafenib and trametinib combination.Ir J Med Sci2025https://conductscience.org/library/papers/40063190PubMed
333841154The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 Melanoma.Front Pharmacol2021https://conductscience.org/library/papers/33841154PubMed
432626712Histone Deacetylase Inhibitors to Overcome Resistance to Targeted and Immuno Therapy in Metastatic Melanoma.Front Cell Dev Biol2020https://conductscience.org/library/papers/32626712PubMed
534831014IGF1R/IR Mediates Resistance to BRAF and MEK Inhibitors in BRAF-Mutant Melanoma.Cancers (Basel)2021https://conductscience.org/library/papers/34831014PubMed
634304249Targeting mTOR signaling overcomes acquired resistance to combined BRAF and MEK inhibition in BRAF-mutant melanoma.Oncogene2021https://conductscience.org/library/papers/34304249PubMed
733364196How Autophagy Shapes the Tumor Microenvironment in Ovarian Cancer.Front Oncol2020https://conductscience.org/library/papers/33364196PubMed
838946469Encorafenib and binimetinib followed by radiotherapy for patients with BRAFV600-mutant melanoma and brain metastases (E-BRAIN/GEM1802 phase II study).Neuro Oncol2024https://conductscience.org/library/papers/38946469PubMed
929950559Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy.Nat Commun2018https://conductscience.org/library/papers/29950559PubMed
1039303722Integrated multi-omics analysis of zinc-finger proteins uncovers roles in RNA regulation.Mol Cell2024https://conductscience.org/library/papers/39303722PubMed
1139175042Characterization of two melanoma cell lines resistant to BRAF/MEK inhibitors (vemurafenib and cobimetinib).Cell Commun Signal2024https://conductscience.org/library/papers/39175042PubMed
1238008717Upregulated expression of miR-4443 and miR-4488 in drug resistant melanomas promotes migratory and invasive phenotypes through downregulation of intermediate filament nestin.J Exp Clin Cancer Res2023https://conductscience.org/library/papers/38008717PubMed
1338593916Development and in-depth characterization of BRAFi-resistant melanoma cell lines in vitro and in vivo.Exp Cell Res2024https://conductscience.org/library/papers/38593916PubMed
1440683333Deep Learning-Guided Quantitative Analysis Establishes Optimized BRAF V600E Immunohistochemical Criteria for Colorectal Cancer: A Multiplatform Validation Study.Lab Invest2025https://conductscience.org/library/papers/40683333PubMed
1533827917Epigenetic reprogramming of tumor cell-intrinsic STING function sculpts antigenicity and T cell recognition of melanoma.Proc Natl Acad Sci U S A2021https://conductscience.org/library/papers/33827917PubMed
1636559089Encorafenib Acts as a Dual-Activity Chemosensitizer through Its Inhibitory Effect on ABCC1 Transporter In Vitro and Ex Vivo.Pharmaceutics2022https://conductscience.org/library/papers/36559089PubMed
1734994998Curcumin suppresses cell proliferation and triggers apoptosis in vemurafenib-resistant melanoma cells by downregulating the EGFR signaling pathway.Environ Toxicol2022https://conductscience.org/library/papers/34994998PubMed
1839297891Neddylation signaling inactivation by tetracaine hydrochloride suppresses cell proliferation and alleviates vemurafenib-resistance of melanoma.Cell Biol Toxicol2024https://conductscience.org/library/papers/39297891PubMed
1932283823Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer with ALK Rearrangement.Int J Mol Sci2020https://conductscience.org/library/papers/32283823PubMed
2038614086Genomic deletions explain the generation of alternative BRAF isoforms conferring resistance to MAPK inhibitors in melanoma.Cell Rep2024https://conductscience.org/library/papers/38614086PubMed

See all 399 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42898919miRNAs bridging the gap between the tumor microenvironment and liquid biopsy in cutaneous melanoma.Front Immunol2026https://conductscience.org/library/papers/42898919PubMed
42891779From MAPK Reactivation to Response: Clinical Approaches Targeting BRAF/MEK Resistance in Melanoma.Am J Clin Dermatol2026https://conductscience.org/library/papers/42891779PubMed
42797320Development of Degradable Silylated Castor Oil-Based Microparticles for the Sustained Release of a Lipophilic Anti-Cancer Drug.Pharmaceutics2026https://conductscience.org/library/papers/42797320PubMed
42729668TET2 downregulation limits oxidative stress-induced cytotoxicity of high dose ascorbate in dabrafenib-resistant melanoma cells.Cancer Drug Resist2026https://conductscience.org/library/papers/42729668PubMed
42553881Elucidating the Nexus of Mitochondrial Dysfunction and Oncometabolite Accumulation in Tumorigenesis.Niger Med J2026https://conductscience.org/library/papers/42553881PubMed
42429842Exploring the apoptotic potential of Prunus spinosa Trigno extract in BRAF-mutated melanoma cells.Mol Biol Rep2026https://conductscience.org/library/papers/42429842PubMed

Download CSV of cited by

Genes202

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243NCBI Gene
ABCB610058PubTator's text mininghttps://conductscience.org/library/genes/10058NCBI Gene
ABCC14363PubTator's text mininghttps://conductscience.org/library/genes/4363NCBI Gene
ABL227PubTator's text mininghttps://conductscience.org/library/genes/27NCBI Gene
ACSS255902PubTator's text mininghttps://conductscience.org/library/genes/55902NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
ALDH1A1216PubTator's text mininghttps://conductscience.org/library/genes/216NCBI Gene
ALDH1A3220PubTator's text mininghttps://conductscience.org/library/genes/220NCBI Gene
ALDH2217PubTator's text mininghttps://conductscience.org/library/genes/217NCBI Gene
AMBRA155626PubTator's text mininghttps://conductscience.org/library/genes/55626NCBI Gene
AMD1262PubTator's text mininghttps://conductscience.org/library/genes/262NCBI Gene
ANAPC1151529PubTator's text mininghttps://conductscience.org/library/genes/51529NCBI Gene
AR367PubTator's text mininghttps://conductscience.org/library/genes/367NCBI Gene
BMAL1406PubTator's text mininghttps://conductscience.org/library/genes/406NCBI Gene
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673NCBI Gene
BSG682PubTator's text mininghttps://conductscience.org/library/genes/682NCBI Gene
CARD16114769PubTator's text mininghttps://conductscience.org/library/genes/114769NCBI Gene
CARF79800PubTator's text mininghttps://conductscience.org/library/genes/79800NCBI Gene
CASP3836PubTator's text mininghttps://conductscience.org/library/genes/836NCBI Gene
CAVIN1284119PubTator's text mininghttps://conductscience.org/library/genes/284119NCBI Gene

See all 202 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41807883

GET https://conductscience.org/api/papers/v1/41807883/references?page=2